| Filed On | Filing |
|---|---|
| 19 Oct 2026 |
8-K: Other Events
BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for HelixTM Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter |
| 07 Oct 2026 |
8-K: Other Events
SUNNYVALE, Calif. – October 7, 2026 – BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the upcoming presentation of a sc... |
| 01 Oct 2026 |
8-K: Other Events
SUNNYVALE, Calif. – October 1, 2026 – BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported it has completed its revised Pre-S... |
| 23 Sep 2026 |
8-K: Other Events
SUNNYVALE, Calif. – September 23, 2026 – BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today provided an update on near term milestones. |
| 21 Sep 2026 |
8-K: Other Events
As previously disclosed, on August 19, 2026, BioCardia, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The NASDAQ Stock Market, LLC (“Nasdaq”) indicating that, for the last 30 consecuti... |
| 10 Sep 2026 |
8-K: Other Events
SUNNYVALE, Calif. – September 10, 2026 – BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that Peter Altman, Ph.D., Pres... |
| 24 Aug 2026 | 8-K: Regulation FD Disclosure |
| 21 Aug 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule |
| 12 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 18 Jun 2026 | 8-K: Regulation FD Disclosure |
| 12 Jun 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule |
| 08 Jun 2026 | 8-K: Other Events |
| 05 Jun 2026 | 8-K: Regulation FD Disclosure |
| 28 May 2026 | 8-K: Regulation FD Disclosure |
| 21 May 2026 | 8-K: Regulation FD Disclosure |
| 15 May 2026 | 8-K: Results of Operations and Financial Condition |
| 08 May 2026 | 8-K: Regulation FD Disclosure |
| 28 Apr 2026 | 8-K: Other Events |
| 20 Apr 2026 | 8-K: Regulation FD Disclosure |
| 15 Apr 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule |
Loading...
